Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Other Long-Term Liabilities : $70 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Other Long-Term Liabilities?

Shandong Weigao Group Medical Polymer Co's other long-term liabilities for the quarter that ended in Dec. 2023 was $70 Mil.

Shandong Weigao Group Medical Polymer Co's quarterly other long-term liabilities declined from Dec. 2022 ($45 Mil) to Jun. 2023 ($45 Mil) but then increased from Jun. 2023 ($45 Mil) to Dec. 2023 ($70 Mil).

Shandong Weigao Group Medical Polymer Co's annual other long-term liabilities declined from Dec. 2021 ($132 Mil) to Dec. 2022 ($45 Mil) but then increased from Dec. 2022 ($45 Mil) to Dec. 2023 ($70 Mil).

Shandong Weigao Group Medical Polymer Co Other Long-Term Liabilities Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Other Long-Term Liabilities Chart

Shandong Weigao Group Medical Polymer Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Shandong Weigao Group Medical Polymer Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Shandong Weigao Group Medical Polymer Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (OTCPK:SHWGY) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

SHWGF:USA 01066:Hong Kong UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Headlines

From GuruFocus

ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products

By PRNewswire PRNewswire • 04-08-2019

Shandong Weigao Group Medical Polymer Co Ltd's Dividend Analysis

By GuruFocus Research • 10-26-2023